Guilherme H. Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guilherme H. Oliveira has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Avirup Guha
Division of Cardiology, Department of Medicine Medical College of Georgia at Augusta University Augusta Georgia USA
2 shared publications Amit K. Dey
National Heart, Lung and Blood Institute, Bethesda, MD, USA
1 shared publicationArjun Ghosh
Cardio-Oncology Service, Bart's Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Cardio-Oncology Service, University College London Hospital, Hatter Cardiovascular Institute, London, United Kingdom
1 shared publicationClaire Roddie
Department of Hematology, University College London Hospital, London, United Kingdom
1 shared publicationDaniel Addison
Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
1 shared publicationIsaac B. Rhea
Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA
1 shared publication
Latest Publications
- Open Access
- 1 December 2020
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 26 (12) , 2211-2216
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis
- 1 December 2020
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 26 (12) , 2211-2216
Open AccessCardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis
- 31 October 2020
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 56 (3) , 544-551
Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation
The purpose of this review is to provide a framework for the cardiovascular evaluation and management of patients undergoing hematopoietic cell transplantation (HCT). To accomplish this, we have performed an extensive literature review, critically analyzed the available evidence, and developed a set of recommendations to guide best practice. Herein, we discuss the cardiovascular risk profile of patients undergoing HCT along with putative mechanisms of HCT-induced cardiovascular injury. We then present an algorithm for cardiovascular testing and risk mitigation of potential recipients. Last, we address the management of the most prevalent cardiovascular conditions associated with HCT recipients.
- 31 October 2020
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 56 (3) , 544-551
Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation
The purpose of this review is to provide a framework for the cardiovascular evaluation and management of patients undergoing hematopoietic cell transplantation (HCT). To accomplish this, we have performed an extensive literature review, critically analyzed the available evidence, and developed a set of recommendations to guide best practice. Herein, we discuss the cardiovascular risk profile of patients undergoing HCT along with putative mechanisms of HCT-induced cardiovascular injury. We then present an algorithm for cardiovascular testing and risk mitigation of potential recipients. Last, we address the management of the most prevalent cardiovascular conditions associated with HCT recipients.